 | Up a level |
Braun, Till, Stachelscheid, Johanna 
ORCID: 0000-0001-7419-8900, Bley, Nadine, Oberbeck, Sebastian, Otte, Moritz, Muller, Tony Andreas, Wahnschaffe, Linus, Glass, Markus ORCID: 0000-0003-2718-8907, Ommer, Katharina, Franitza, Marek, Gathof, Birgit, Altmueller, Janine, Hallek, Michael ORCID: 0000-0002-7425-4455, Auguin, Daniel ORCID: 0000-0003-4713-9096, Huettelmaier, Stefan, Schrader, Alexandra and Herling, Marco
(2022).
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.
Cancer Res., 82 (9).
S. 1818 - 1832.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1538-7445
Cuesta-Mateos, Carlo, Fuentes, Patricia ORCID: 0000-0003-4597-1022, Schrader, Alexandra, Juarez-Sanchez, Raquel, Loscertales, Javier, Mateu-Albero, Tamara, Vega-Piris, Lorena, Espartero-Santos, Marina, Marcos-Jimenez, Ana, Sanchez-Lopez, Blanca Andrea, Perez-Garcia, Yaiza, Jungherz, Dennis, Oberbeck, Sebastian, Wahnschaffe, Linus, Kreutzman, Anna, Andersson, Emma I., Mustjoki, Satu ORCID: 0000-0002-0816-8241, Faber, Edgar, Urzainqui, Ana, Fresno, Manuel, Stamatakis, Kostantino, Alfranca, Arantzazu ORCID: 0000-0002-3732-5816, Terron, Fernando, Herling, Marco, Toribio, Maria Luisa and Munoz-Calleja, Cecilia
(2020).
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Biomark. Res., 8 (1).
LONDON:
BMC.
ISSN 2050-7771
Herling, Carmen D., Abedpour, Nima, Weiss, Jonathan, Schmitt, Anna, Jachimowicz, Ron Daniel, Merkel, Olaf ORCID: 0000-0001-5089-344X, Cartolano, Maria, Oberbeck, Sebastian, Mayer, Petra, Berg, Valeska, Thomalla, Daniel, Kutsch, Nadine, Stiefelhagen, Marius, Cramer, Paula, Wendtner, Clemens-Martin ORCID: 0000-0003-2866-2260, Persigehl, Thorsten, Saleh, Andreas, Altmueller, Janine, Nuernberg, Peter, Pallasch, Christian, Achter, Viktor, Lang, Ulrich, Eichhorst, Barbara, Castiglione, Roberta ORCID: 0000-0002-9828-4405, Schaefer, Stephan C., Buettner, Reinhard, Kreuzer, Karl-Anton, Reinhardt, Hans Christian, Hallek, Michael, Frenzel, Lukas P. and Peifer, Martin ORCID: 0000-0002-5243-5503
(2018).
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.
Nat. Commun., 9.
LONDON:
NATURE PUBLISHING GROUP.
ISSN 2041-1723
Kotrova, Michaela ORCID: 0000-0001-5394-1072, Novakova, Michaela, Oberbeck, Sebastian, Mayer, Petra, Schrader, Alexandra, Knecht, Henrik, Hrusak, Ondrej, Herling, Marco and Brueggemann, Monika
(2018).
Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric V beta expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases.
Cytom. Part A, 93A (11).
S. 1118 - 1125.
HOBOKEN:
WILEY.
ISSN 1552-4930
Meder, Lydia ORCID: 0000-0002-9547-5812, Schuldt, Philipp, Thelen, Martin ORCID: 0000-0002-2785-9726, Schmitt, Anna, Dietlein, Felix, Klein, Sebastian, Borchmann, Sven, Wennhold, Kerstin, Vlasic, Ignacija, Oberbeck, Sebastian, Riedel, Richard, Florin, Alexandra, Golfmann, Kristina, Schloesser, Hans A., Odenthal, Margarete, Buettner, Reinhard, Wolf, Juergen, Hallek, Michael, Herling, Marco, von Bergwelt-Baildon, Michael, Reinhardt, H. Christian and Ullrich, Roland T.
(2018).
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.
Cancer Res., 78 (15).
S. 4270 - 4282.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1538-7445
Pflug, Natali, Cramer, Paula, Robrecht, Sandra, Bahlo, Jasmin, Westermann, Anne, Fink, Anna-Maria, Schrader, Alexandra, Mayer, Petra, Oberbeck, Sebastian, Seiler, Till, Zenz, Thorsten, Duerig, Jan, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael, Herling, Marco and Hopfinger, Georg (2019). New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leuk. Lymphoma, 60 (3). S. 649 - 658. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403